monoclonal antibody (BioFactura)

N/A

Report date: 2025/03/20 15:35:40

Base Information

Drug Namemonoclonal antibody (BioFactura)
Drug Alias NameSudan ebola therapeutic (BioFactura)IID F6-H2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioFactura Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioFactura Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A